| Trial ID: | L5413 |
| Source ID: | NCT03282136
|
| Associated Drug: |
Incretin Effect
|
| Title: |
Incretin and CRTd.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Heart Failure
|
| Interventions: |
DRUG: Incretin Effect|DEVICE: Cardiac Resynchronization therapy defibrillator device
|
| Outcome Measures: |
Primary: all cause mortality, and cardiac cause mortality., 12 months | Secondary: hospital admissions for HF, 12 months
|
| Sponsor/Collaborators: |
Sponsor: University of Campania Luigi Vanvitelli
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
500
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2017-09-01
|
| Completion Date: |
2017-09-01
|
| Results First Posted: |
|
| Last Update Posted: |
2017-09-13
|
| Locations: |
Raffaele Marfella, Naples, 80128, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT03282136
|
